GLP1R and psoriasis: Findings persisted across subgroup and sensitivity analyses.<h4>Conclusion</h4>In a large, real-world study designed to emulate a clinical trial, GLP-1 RAs were linked to increased psoriasis and decreased autoimmune blistering diseases compared with DPP-4is over up to 4 years' follow-up.